From $250K/yr
About the role Sana Biotechnology is growing, and we are hiring new team members who believe in the potential of engineered cells as medicines, who want to challenge status quo, and who lead with the desire to translate novel ideas into clinical and commercial product. As the Senior Director, Late-Stage Cell Therapy Process Development, you will report to the Head of Process and Analytical Development and provide strategic, technical leadership for late stage process development of a PSC-derived islet product for Type 1 diabetes. You will build and manage a high performing process development team to develop commercial ready manufacturing processes. You will play a critical role in advancing our pipeline through pivotal process development, technology transfer, process characterization, and commercial readiness, ensuring robust, scalable, and compliant manufacturing processes. Cool Stuff! This role will require onsite leadership in Cambridge, MA. What you’ll do Partner closely with Research to develop 3D stem cell seed train and differentiation processes, including integration of bioreactors and automated and closed technologies and drug product (DP) process-enabling studies including formulation, fill/finish, and cryopreservation. Lead late stage process development for PSC-derived products, ensuring scalability, robustness, quality and regulatory compliance. Lead process characterization and validation activities, leveraging design of experiments (DoE) and Quality by Design (QbD) approaches and support process performance qualification (PPQ). Establish and execute a comparability strategy for pivotal process changes. Enable technology transfer to CDMOs or internal manufacturing, providing technical input and ensuring successful implementation. Author and review CMC sections of regulatory submissions (e.g., IND, BLA) and support regulatory Q&A and inspections. Collaborate and influence partners across multidisciplinary teams (e.g. Research, Analytical Dev
